Drawing for M MENARINI

USPTO serial 79295192

M MENARINI

Reviewed by CopyMark Law Group

Reg. 6391997Status 700Renewal
Filing date
Status date
Registration date
Jun 22, 2021
Examiner
VENGROFF, MARILYN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with M MENARINI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated soaps for personal use; perfumery; essential oils; cosmetics; soothing cosmetic formulations being cosmetics; cosmetic sun care preparations; skin cleansers; skin moisturizer; skin cleansing lotion; cosmetic skin masks; non-medicated cosmetic products in the form of non-medicated creams, gels, emulsions, foam and soaps with an effect on the appearance of the skin in relation to signs and symptoms associated with acne; non-medicated cosmetics with a dermatological effect on the appearance of the skin; purifying and moisturizing gel for acne-prone skin; skin lighteners; cosmetic preparations for skin renewal; concealers for spots and blemishes; skin whitening preparations; non-medicated skin exfoliating preparations; non-medicated skin serums; cosmetic skin care lotions; wrinkle removing skin care preparations; skin moisturizers used as cosmetics; topical skin sprays for cosmetic purposes; cosmetic blemish balm creams; cosmetic cleansing creams; cosmetic creams for dry skin; cosmetics for the treatment of dry skin; cosmetic preparations for dry skin during pregnancy; cosmetics for dermatological use, namely, non-medicated cosmetic skin care preparations; skin cleansing lotions; cosmetic cleansing oils for personal use; cosmetic preparations for baths; shower and bath foam; non-medicated bath oils; facial cleansers; body cleaning and beauty care cosmetic preparations; hair care preparations and non-medicated hair treatments for cosmetic purposes; bath oil; body oils for cosmetic use; cosmetic oils for the epidermisACTIVE
005Antibiotics; anti-cancer preparations; diagnostic reagents for use in medical clinics; diagnostic test reagents for medical use for testing body fluids for microorganisms; diagnostic kits composed of diagnostic agents, preparations and substances for medical use in disease testing; indicators for medical diagnosis, namely, biological indicators for monitoring sterilization processes; in vitro diagnostic preparations being reagents for medical purposes; medicated dermatological preparations for treating signs and symptoms associated with acne; medical and sanitary preparations in particular curative cosmetics for medical purposes; hyaluronic acid for pharmaceutical purposes; dermatological pharmaceutical products; creams for dermatological use; gel for dermatological use; antimicrobials for dermatological use; injectable dermal filler; medicated skin creams; medicated skin tonics; pharmaceutical lotions for the skin; medicated skin lotions; medicinal creams for skin protection; medicated skin care lotions; pharmacological preparations being pharmaceuticals for skin care; pharmaceutical preparations for skin care; medicinal creams for skin care; prepared skin exfoliants for medical purposes; emollients for medical purposes; tissue-regenerative pharmaceutical preparations; topical gels for medical and therapeutic purposes for the treatment of cold and flu; pharmaceutical preparations for the treatment of inflammatory disorders; medicated preparations for skin treatment; pharmaceutical preparations for treating skin disorders; acne medications; pharmaceutical preparations, namely, acne creams; pharmaceutical preparations, namely, acne cleansers; niacinamide-based preparations for the treatment of acne; acne treatment preparationsACTIVE
009Computer hardware and recorded computer software for collection, organization, analysis, integration and communication of scientific records, in the nature of downloadable software and preloaded software; equipment for carrying out biological, clinical, physical and chemical physical analyses, namely, labs-on-a-chip, cytometers and analyzers providing cell and particle analysis, detection, sorting or counting; equipment for the synthesis of chemical and biological substances, namely, labs-on-a-chip; equipment for cell manipulation; namely, precision instruments for manipulation and positioning of microscopics; biochips and biosensors for detecting diseases for research and scientific purposes; electric, electronic, magnetic and optical memory units namely, semi-conductor memory units for storing information such as images and analysis results data; clinical, laboratory and analytical instruments and microfluidic devices, namely, cell sorters, microscopes and cell separation devices; instrumental components and laboratory complementing instruments, namely, computer hardware and peripheralsACTIVE
010Equipment and instruments being apparatus for blood testing, blood analysis, and genetic analysis in the field of reproductive health, oncology, cell sorting and manipulation devices for use in the medical, diagnostic and pharmaceutical fields; equipment and instruments being apparatus for stem cells isolation and processing, in regenerative medicine, namely, microfabricated cell-sorter chips and control equipment; apparatus for diagnosing human genetic disease and tumors; components and accessories for the aforesaid equipment and instruments, namely, biochips for cell sorting, biochips for sample preparation for use in medical purposes; surgical apparatus and instruments; surgical threads; threads for facelift used in plastic surgery; needles for medical purposes; syringes and injectors for medical purposes; automated blood separation instruments; autologous blood recovery apparatus and autologous blood processing apparatus for medìcal purposes; filters for blood and blood components for medìcal purposes; medical apparatus for the preparation of PRP - platelet rich plasma; hypodermic needles; surgical needles; multishot needle syringes for medìcal purposes; injection instruments without needles; hypodermic injectors; medication injectors; jet injectors for medical use; apparatus for acne treatment; suture and wound closing materials and products, namely, medical devices for closing wounds and surgical thread, namely, cooling patches for medical purposes, suture needles, sutures, surgical staples, surgical staple removersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 22, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 18, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 18, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 18, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 18, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 15, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 15, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 15, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 13, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Oct 13, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB
Oct 13, 2021XXCRGENERIC MADRID TRANSACTION CREATED
Sep 22, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 22, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 6, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 6, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2021GPNXNOTIFICATION PROCESSED BY IB
Mar 17, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 17, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2020RFNTREFUSAL PROCESSED BY IB
Nov 16, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 16, 2020RFRRREFUSAL PROCESSED BY MPU
Oct 31, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 30, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2020DOCKASSIGNED TO EXAMINER
Oct 17, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Oct 13, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance